RLMD
#3077
Relmada Therapeutics, Inc. - Common Stock
3.3 8 USD
-0.04%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-3.70%
Variazione Mensile
-25.39%
Variazione di 6 mesi
-54.81%
Variazione Annuale
+70.71%
Chiusura Precedente
3.5 1
Open
3.5 0
Minimo
3.3 6
Massimo
3.5 5
Financials
2020
Current report, 14 Dec 2020
RELMADA THERAPEUTICS, INC. current report, 14 December 2020
8-K
Current report, 07 Dec 2020
RELMADA THERAPEUTICS, INC. current report, 07 December 2020
8-K
Current report, 16 Nov 2020
RELMADA THERAPEUTICS, INC. current report, 16 November 2020
8-K
Current report, 27 Oct 2020
RELMADA THERAPEUTICS, INC. current report, 27 October 2020
8-K
Quarterly report, Q3 FY2020
RELMADA THERAPEUTICS, INC. quarterly report, Q3 FY2020
10-Q
Quarterly report, Q2 FY2020
RELMADA THERAPEUTICS, INC. quarterly report, Q2 FY2020
10-Q
Current report, 02 Jun 2020
RELMADA THERAPEUTICS, INC. current report, 02 June 2020
8-K
Quarterly report, Q1 FY2020
RELMADA THERAPEUTICS, INC. quarterly report, Q1 FY2020
10-Q
Current report, 06 Mar 2020
RELMADA THERAPEUTICS, INC. current report, 06 March 2020
8-K
Current report, 06 Mar 2020
RELMADA THERAPEUTICS, INC. current report, 06 March 2020
8-K